Repository logo
 

Mitochondrial heteroplasmy beyond the oocyte bottleneck.

Accepted version
Peer-reviewed

No Thumbnail Available

Type

Article

Change log

Authors

van den Ameele, Jelle 
Li, Andy YZ 
Chinnery, Patrick F 

Abstract

Inheritance of the mitochondrial genome does not follow the rules of conventional Mendelian genetics. The mitochondrial DNA (mtDNA) is present in many copies per cell and is inherited through the maternal germline. In addition, mutations in the mtDNA will give rise to heteroplasmy, the coexistence of different mtDNA variants within a single cell, whose levels can vary considerably between cells, organs or organisms. The inheritance and subsequent accumulation of deleterious variants are the cause of severe progressive mitochondrial disorders and play a role in many other conditions, including aging, cancer and neurodegenerative disorders. Here, we discuss the processes that give rise to cell-to-cell variability in mtDNA composition, focussing on somatic mtDNA segregation and on less conventional sources of heteroplasmy: non-maternal inheritance and mtDNA recombination. Understanding how mtDNA variants and mutations emerge and evolve within an organism is of crucial importance to prevent and cure mitochondrial disease and can potentially impact more common aging-associated conditions.

Description

Keywords

Bottleneck, Heteroplasmy, Mitochondrial genome, Paternal leakage, Recombination, Somatic segregation, Female, Humans, Mitochondria, Oocytes

Journal Title

Semin Cell Dev Biol

Conference Name

Journal ISSN

1084-9521
1096-3634

Volume Title

97

Publisher

Elsevier BV
Sponsorship
Wellcome Trust (202269/Z/16/Z)
Wellcome Trust (105839/Z/14/Z)
Wellcome Trust (212219/Z/18/Z)
EMBO Long-term Fellowship (ALTF 1600_2014) Wellcome Trust Postdoctoral Training Fellowship for Clinicians (105839). Wellcome Trust Sir Henry Dale Fellow (202269/Z/16/Z) Wellcome Trust Principal Research Fellow (212219/Z/18/Z) UK NIHR Senior Investigator Support from the Medical Research Council Mitochondrial Biology Unit (MC_UP_1501/2), the Evelyn Trust, and the National Institute for Health Research (NIHR) Biomedical Research Centre